![discount label](https://static.cymitquimica.com/public/img/discount.png)
CLEC9A Protein, Human, Recombinant (hFc)
Rif. TM-TMPK-01057
1mg | 2.658,00 € | ||
100µg | 419,00 € | ||
500µg | 1.585,00 € |
Informazioni sul prodotto
- CD370, UNQ9341, DNGR-1, HEEE9341, 9830005G06Rik, CLEC9A
CLEC9A expression was significantly higher in psoriatic skin compared with healthy donor. In psoriatic skin and PsA ST, CLEC9A() cells were in close proximity to TUNEL() cells. SF CLEC9A levels were significantly lower compared with paired PsA serum. Adalimumab treatment did not affect CLEC9A serum level and skin expression. The downregulation of synovial CLEC9A might be associated with a novel mechanism by which anti-TNF therapy might reduce CD8-mediated inflammation in PsA patients.
Proprietà chimiche
Richiesta tecnica su: TM-TMPK-01057 CLEC9A Protein, Human, Recombinant (hFc)
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.